Last reviewed · How we verify

Sunscreen oil with 6% Bemotrizinol

dsm-firmenich Switzerland AG · Phase 2 active Small molecule

Sunscreen oil with 6% Bemotrizinol is a Small molecule drug developed by dsm-firmenich Switzerland AG. It is currently in Phase 2 development. Also known as: PARSOL® SHIELD, SU E 101413 85.

At a glance

Generic nameSunscreen oil with 6% Bemotrizinol
Also known asPARSOL® SHIELD, SU E 101413 85
Sponsordsm-firmenich Switzerland AG
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Sunscreen oil with 6% Bemotrizinol

What is Sunscreen oil with 6% Bemotrizinol?

Sunscreen oil with 6% Bemotrizinol is a Small molecule drug developed by dsm-firmenich Switzerland AG.

Who makes Sunscreen oil with 6% Bemotrizinol?

Sunscreen oil with 6% Bemotrizinol is developed by dsm-firmenich Switzerland AG (see full dsm-firmenich Switzerland AG pipeline at /company/dsm-firmenich-switzerland-ag).

Is Sunscreen oil with 6% Bemotrizinol also known as anything else?

Sunscreen oil with 6% Bemotrizinol is also known as PARSOL® SHIELD, SU E 101413 85.

What development phase is Sunscreen oil with 6% Bemotrizinol in?

Sunscreen oil with 6% Bemotrizinol is in Phase 2.

Related